Výsledky vyhledávání - "Martin Helsing"

Swedish Lung Cancer Radiation Study Group: Predictive value of age at diagnosis for radiotherapy response in patients with non-small cell lung cancer

Autor: Georg Holgersson, Margareta Holgersson, Jan Nyman, Stefan Bergström, Lars Ekberg, Signe Friesland, Martin Helsing, Sven-Börje Ewers, Charlotte Mörth, Thomas Blystad, Michael Bergqvist, Even Hoye, Britta Lödén, Simon Ekman, Roger Henriksson

Publikováno v: Acta Oncologica. 51:759-767

The aim of the present study was to investigate the impact of age at diagnosis on prognosis in patients treated with curatively intended radiotherapy for NSCLC.This is a joint effort among all the Swedish Oncology Departments that includes all identi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f97c76da103d762c7a974f8465dac92
https://doi.org/10.3109/0284186x.2012.681064

Zobrazit plný text záznamu

Prognostic Factors for the Survival of Surgically Treated Patients for Non-Small Cell Lung Cancer

Autor: Stig-Olof Almgren, Mats G. Karlsson, Oswaldo Fernandes, Domingos S. R. Souza, Martin Helsing, Anders Magnusson, Derek Filbey, Lars Thaning

Publikováno v: Acta Oncologica. 42:338-341

The survival and outcome rates of 284 patients who underwent surgical treatment for non-small cell lung cancer were assessed retrospectively. Resectability rate was 94.1%, hospital mortality 3.9% (n = 11) and the mortality rates in patients who under

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfb077faf9db6e869871c70173ec4ba5
https://doi.org/10.1080/02841860310003536

Zobrazit plný text záznamu

Treatment with paclitaxel 1-h infusion and carboplatin of patients with advanced non-small-cell lung cancer: a phase II multicentre trial

Autor: Tryggve Månsson, Dariush Anjedani, Christer Sederholm, Ulf Hero, Jan-Erik Martinsson, Lars Thaning, Kristina Lamberg, Gunnar Svennson, Lars Andersson, Martin Helsing, Lars Ek

Publikováno v: Lung Cancer. 24:107-113

The primary aim of this phase II study was to determine the response rate of a combination of paclitaxel and carboplatin in advanced non-small cell lung cancer (NSCLC) in a multicentre setting. The secondary aim was to determine time to progression (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9b3d8558ecf5d980c24fa548cf3904da
https://doi.org/10.1016/s0169-5002(99)00027-6

Zobrazit plný text záznamu

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial

Autor: Martin Helsing, Lars Thaning, U Hero, Bengt Bergman

Publikováno v: European Journal of Cancer. 34:1036-1044

The aim of the present trial was to evaluate the effects of chemotherapy on the quality of life and survival of patients with advanced non-small cell lung cancer (NSCLC) (stage IIIB or IV). In a controlled multicentre trial, patients were randomised

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cf9fbf14212dd6976eb4b7f32b21c118
https://doi.org/10.1016/s0959-8049(97)10122-8

Zobrazit plný text záznamu

The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer

Autor: Roger Henriksson, Sven-Börje Ewers, Margareta Holgersson, Simon Ekman, Michael Bergqvist, Stefan Bergström, Martin Helsing, Even Hoye, Georg Holgersson, Jan Nyman, Charlotte Mörth, Britta Lödén, Thomas Blystad, Lars Ekberg, Signe Friesland

Publikováno v: Medical oncology (Northwood, London, England). 30(1)

The prognosis for patients with lung cancer is poor with an average of 5-year overall survival rate of only 10-15 % taking all clinical stages together. The aim of this study was to elucidate the impact of the radiotherapy regimen on survival. Clinic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68db80f41ea4c64460d9cc4d2b8e4765
https://pubmed.ncbi.nlm.nih.gov/23254960

Zobrazit plný text záznamu

The value of induction chemotherapy for survival in patients with non-small cell lung cancer treated with radiotherapy

Autor: Georg, Holgersson, Martin, Sandelin, Even, Hoye, Stefan, Bergström, Roger, Henriksson, Simon, Ekman, Jan, Nyman, Martin, Helsing, Signe, Friesland, Ola, Brodin, Margareta, Holgersson, Kristina Lamberg, Lundström, Christer, Janson, Lars, Ekberg, Charlotte, Mörth, Thomas, Blystad, Sven-Börje, Ewers, Britta, Löden, Michael, Bergqvist

Publikováno v: Anticancer research. 32(4)

The aim of the present study was to retrospectively investigate the impact of induction chemotherapy on treatment outcome in patients treated with curatively intended radiotherapy for non-small cell lung cancer (NSCLC).Patients with a diagnosed NSCLC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::204e8375b494d54fd1a30959c0e84617
https://pubmed.ncbi.nlm.nih.gov/22493368

Zobrazit plný text záznamu

Swedish lung cancer radiation study group: predictive value of histology for radiotherapy response in patients with non-small cell lung cancer

Autor: Simon Ekman, Roger Henriksson, Margareta Holgersson, Britta Lödén, Georg Holgersson, Jan Nyman, Thomas Blystad, Stefan Bergström, Elisabet Birath, Sven-Börje Ewers, Michael Bergqvist, Even Hoye, Charlotte Mörth, Signe Friesland, Martin Helsing

Publikováno v: European journal of cancer (Oxford, England : 1990). 47(16)

The aim of the present study was to evaluate the potential predictive value of histology in non-small cell lung cancer (NSCLC) treated with curatively intended radiotherapy. In a collaborative effort among all the Swedish Oncology Departments, clinic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57b590304927ac51e8bef30e27cdce18
https://pubmed.ncbi.nlm.nih.gov/21726999

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání